Kewaunee Scientific to Attend the 2025 Arablab Live Trade Show in Dubai

Rhea-AI Summary

Kewaunee Scientific Corporation (NASDAQ: KEQU) has announced its participation in the 2025 Arablab Live tradeshow in Dubai from September 23-25. The company will showcase its comprehensive portfolio, including products from its newly acquired subsidiary NuAire, and its healthcare brand EVERHUTCH.

Visitors can explore Kewaunee's booth at Hall 1, Stand F80 of the Dubai World Trade Centre, featuring demonstrations of new Revit design tools for laboratory planning. The presentation will highlight the company's integrated expertise in laboratory infrastructure, biosafety, healthcare environments, and data-informed lab design through its partnership with Koncepo.

STATESVILLE, N.C., Sept. 2, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company will attend the 2025 Arablab Live tradeshow and conference, taking place in Dubai from September 23-25.

This year, attendees can look forward to product demonstrations and the opportunity to connect with representatives from Kewaunee's corporate and international teams, newly acquired containment and biosafety powerhouse NuAire, and the Company's healthcare brand EVERHUTCH. The Company will also share market insights from its research partner Koncepo. Together, these groups represent the full strength of Kewaunee, offering integrated expertise in laboratory infrastructure, biosafety, healthcare environments, and data-informed lab design.

Visitors to Arablab are invited to explore the Kewaunee booth, located in Hall 1, Stand F80 of the Dubai World Trade Centre, to discover a range of innovative offerings. Highlights will include an in-depth look at Kewaunee's new Revit design tools, built to accelerate lab planning while bringing architectural visions to life with precision and ease.

Kewaunee looks forward to connecting with international partners and customers, exchanging insights, and showcasing how its laboratory-grade solutions continue to advance design, safety, and functionality in laboratory and healthcare spaces around the world.

About Kewaunee Scientific

Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The Company's products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The Company's corporate headquarters are located in Statesville, North Carolina. Sales offices are located in the United States, India, Saudi Arabia, and Singapore. Three manufacturing facilities are located in Statesville, serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India, serving the local, Asian, and African markets. 

Kewaunee Scientific's newly acquired subsidiary, Nu Aire, Inc. ("NuAire"), is a leading manufacturer of biological safety cabinets, CO2 incubators, ultralow freezers, and other essential laboratory products that complement the Kewaunee Scientific portfolio. Founded in 1971, NuAire's headquarters and manufacturing facilities are located in Plymouth, Minnesota, with additional manufacturing capabilities located in Long Lake, Minnesota. The Company also maintains a warehouse partnership in the Netherlands and OEM partnerships in China.

Learn more at the companies' websites, located at https://www.kewaunee.com and https://www.nuaire.com/. 

This press release contains statements that the Company believes to be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this press release, including statements regarding the Company's future financial condition, results of operations, business operations and business prospects, are forward-looking statements. Words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "predict," "believe" and similar words, expressions and variations of these words and expressions are intended to identify forward-looking statements. Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions, and other important factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. Such factors, risks, uncertainties and assumptions include, but are not limited to: our ability to realize the benefits anticipated as a result of the NuAire acquisition; competitive and general economic conditions, including disruptions from government mandates, both domestically and internationally, as well as supplier constraints and other supply disruptions; changes in customer demands; technological changes in our operations or in our industry; dependence on customers' required delivery schedules; risks related to fluctuations in the Company's operating results from quarter to quarter; risks related to international operations, including foreign currency fluctuations; changes in the legal and regulatory environment; changes in raw materials and commodity costs; acts of terrorism, war, governmental action, and natural disasters and other Force Majeure events. The cautionary statements made pursuant to the Reform Act herein and elsewhere by us should not be construed as exhaustive. We cannot always predict what factors would cause actual results to differ materially from those indicated by the forward-looking statements. Over time, our actual results, performance, or achievements will likely differ from the anticipated results, performance or achievements that are expressed or implied by our forward-looking statements, and such difference might be significant and harmful to our stockholders' interest. Many important factors that could cause such a difference are described under the caption "Risk Factors," in Item 1A of our Annual Report on Form 10-K for the most recent fiscal year ended April 30, which you should review carefully, and in our subsequent quarterly reports on Form 10-Q and current reports on Form 8-K. These reports are available on our investor relations website at www.kewaunee.com and on the SEC website at www.sec.gov. These forward-looking statements speak only as of the date of this document. The Company assumes no obligation, and expressly disclaims any obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:	Donald T. Gardner III
	704/871-3274

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/kewaunee-scientific-to-attend-the-2025-arablab-live-trade-show-in-dubai-302543928.html

SOURCE Kewaunee Scientific Corporation

FAQ

When and where is Kewaunee Scientific (KEQU) presenting at Arablab 2025?

Kewaunee Scientific will present at Hall 1, Stand F80 of the Dubai World Trade Centre from September 23-25, 2025.

What products will Kewaunee Scientific showcase at Arablab 2025?

Kewaunee will showcase products from its portfolio including laboratory infrastructure solutions, NuAire biosafety products, EVERHUTCH healthcare products, and new Revit design tools for lab planning.

What are Kewaunee Scientific's (KEQU) manufacturing facilities locations?

Kewaunee has three manufacturing facilities in Statesville, North Carolina, one in Bangalore, India, and through NuAire, facilities in Plymouth and Long Lake, Minnesota.

What is the significance of Kewaunee's NuAire acquisition?

NuAire complements Kewaunee's portfolio as a leading manufacturer of biological safety cabinets, CO2 incubators, ultralow freezers, and other essential laboratory products.